Erythromycin/sulfafurazole: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 40: | Line 40: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
Revision as of 16:48, 10 February 2025
Erythromycin/Sulfafurazole is a combination medication used in the treatment of various bacterial infections. It is a combination of two antibiotics: erythromycin, a macrolide antibiotic, and sulfafurazole, a sulfonamide antibiotic.
Mechanism of Action
Erythromycin works by inhibiting the synthesis of bacterial proteins, thereby preventing the growth and multiplication of bacteria. Sulfafurazole, on the other hand, inhibits the synthesis of folic acid, a vital component for bacterial DNA replication. The combination of these two antibiotics provides a broader spectrum of action against a variety of bacteria.
Indications
Erythromycin/Sulfafurazole is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the diseases listed below:
Side Effects
Like all medications, Erythromycin/Sulfafurazole can cause side effects. These may include:
Precautions
Patients with a history of allergy to macrolides or sulfonamides should avoid this medication. It should also be used with caution in patients with liver or kidney disease.
Interactions
Erythromycin/Sulfafurazole may interact with other medications, including warfarin, phenytoin, and certain antifungal medications. It is important to inform your healthcare provider of all medications you are currently taking.
References
